Well summed up. Who cares about FDA approval, really storm in a tea cup. Need to look at bigger picture of forthcoming earnings report and commentary thereof. Do not sweat on not being able to supply to US market, not really earth shattering profitability wise. Move on...
Deferral is not rejection! This looks like a pause whilst they clean house, page-45
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.85 |
Change
-0.060(0.87%) |
Mkt cap ! $4.952B | |||
| Open | High | Low | Value | Volume |
| $6.83 | $6.87 | $6.78 | $8.532M | 1.250M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2151 | $6.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.85 | 27162 | 5 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| A2M (ASX) Chart |